Latest receivables for MEUSW: $1.2M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2025), MEUSW shows a receivables of $1.2M. That compares with $1.1M in the prior-year period — up 11.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MEUSW's receivables is now $1.2M (was $1.1M) — a 11.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether 23andMe Holding Co - Warrants (16/06/2026) is outperforming or lagging.
Tracking MEUSW's receivables over time shows whether 23andMe Holding Co - Warrants (16/06/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2M That compares with $1.1M in the prior-year period — up 11.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has 23andMe Holding Co - Warrants (16/06/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.2M) with ownership activity and broader fundamentals.
23andMe Holding Co - Warrants (16/06/2026)'s receivables is $1.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.